Corinne Faivre-Finn
www.christie.nhs.uk
0000-0001-5617-9781
University of Manchester
251 papers found
Refreshing results…
Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy.
Efficacy of Positron Emission Tomography Staging for Small-Cell Lung Cancer: A Systematic Review and Cost Analysis in the Australian Setting
Concurrent Chemoradiotherapy for Locally Advanced, Unresectable Non-small Cell Lung Cancer: A UK Survey of Current Practice
13
Stage III non small cell lung cancer: What is evidence based for older patients?
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.
Sp-0407 Current Practice and Moving Points: Lung
Po-0744 Is 14 Day Mortality a Useful Measure of Palliative Radiotherapy Efficacy in Lung Cancer
Radiotherapy Research Trials in the UK: Secrets of Success
Po-0961 Isotoxic Radiotherapy for Non-Small Cell Lung Cancer: Is Imrt the Answer?
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention
159 Quality of life after treatment for brain metastases: An update on the QUARTZ trial – one year on from an interim data release
157 Mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centre
154 Concurrent chemoradiotherapy (cCTRT) for locally-advanced, unresectable non-small cell lung cancer (LA-NSCLC): A national survey of current practice
146 One year on: early report of intensity modulated radiotherapy (IMRT) for locally advanced lung cancer at the Christie
165 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced pulmonary toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)
164 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced oesophageal toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)
168 Experiences of pre-trial quality assurance (QA) for the CONVERT trial. A multicentre randomised phase III trial for good performance status patients with limited stage small cell lung cancer
167 CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A phase III randomised controlled trial for patients with limited stage small cell lung cancer (LS-SCLC) and good performance status
Missing publications? Search for publications with a matching author name.